Protease inhibitors, a new class of HIV therapy

JAMA

Volumn 277, Issue 23, 1997, Pages 1865-1866

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; INFLUENZA VACCINE; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; CYCLOSPORA CAYETANENSIS; HEPATITIS C VIRUS; HEPATITIS VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; COMMUNICABLE DISEASE; EPIDEMIC; FLAVIVIRUS; HERPES VIRUS INFECTION; HUMAN HERPESVIRUS 8; INFECTION; VIRUS HEPATITIS;

ANTI-HIV AGENTS; COMMUNICABLE DISEASES; DISEASE OUTBREAKS; FLAVIVIRIDAE; HEPATITIS, VIRAL, HUMAN; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; INFECTION; PROTEASE INHIBITORS;

EID: 0031577026     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.23.1865     Document Type: Short Survey

References (19)

1. Lederberg J. Infectious disease: a threat to global health and security. JAMA. 1996;276:417-419.
2. Gorman C. Man of the Year: the disease detective. Time. December 30, 1996:56-70.
3. Bloom FE. Breakthroughs of the year, 1996. Science. 1996;274:1987.
4. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV infection. Nature. 1995;373: 123-126.
5. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995;373:117-122.
6. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;72:1167-1170.
7. Fauci A. Host factors and the pathogenesis of HIV-induced disease. Nature. 1996; 384:529-534.
8. Emini EA. Maintenance of long-term virus suppression in patients treated with the protease inhibitor Crixivan (indinavir). In: Program and abstracts of the XI International Conference on AIDS; Vancouver, British Columbia; July 7-12, 1996. Abstract MoB 170.
9. Markowitz M, et al. Triple therapy with AZT, 3TC and ritonavir in 12 patients newly infected with HIV-1. In: Program and abstracts of the XI International Conference on AIDS; Vancouver, British Columbia; July 7-12, 1996. Abstract ThB 933.
10. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA. 1996;275:1483-1488.
11. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. JAMA. 1996;276:146-154.
12. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1996;334:701.
13. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the U.K. Lancet. 1996;347:921-925.
14. Centers for Disease Control and Prevention. Update: outbreaks of Cyclospora cayetanensis infection - United States and Canada, 1996. MMWR Morb Mortal Wkly Rep. 1996;45:611.
15. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1-6.
16. Chang Y, Cesarman E, Pessin MS, et al. Identification of DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865.
17. Foreman KE, Friborg J Jr, Kong W-P, et al. Propagation of a human herpes-virus from AIDS-associated Kaposi's sarcoma. N Engl J Med. 1997;336:163-171.
18. Linnen J, Wages J, Zhangkeck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;71:505-508.
19. Lorber B. Are all diseases infectious? Ann Intern Med. 1996;125:844-851.